- Weigao Medical Polymer signed a land use right transfer agreement to acquire an industrial land use right from Weigao Biotechnology for CNY 39.7 million.
- The land parcel covers about 76,342 sq.m and the land use right expires on April 14, 2070.
- Payment is scheduled in three cash installments of CNY 20 million, CNY 10 million, and CNY 9.7 million.
- Weigao Biotechnology is wholly owned by Weigao Medical Investment Holding, which holds 89.83% of Weigao Holding.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073385), on March 27, 2026, and is solely responsible for the information contained therein.
Comments